Copyright
©2012 Baishideng Publishing Group Co.
World J Radiol. Aug 28, 2012; 4(8): 345-352
Published online Aug 28, 2012. doi: 10.4329/wjr.v4.i8.345
Published online Aug 28, 2012. doi: 10.4329/wjr.v4.i8.345
Table 1 Multidetector computed tomography parameters
Parameter | Value |
Detector collimation | 0.5 to 0.75 |
Pitch | 0.984 |
kVp | 120 |
Contrast | 125 cc of intravenous optiray 350 |
Table 2 Multidetector computed tomography multiphasic acquisition
Phase of image acquisition | Time of acquisition | Section thickness (mm) | Milliamperage (mA) |
Unenhanced liver images | 5 | 250 | |
Arterial phase liver images | Bolus tracking technique or manually at 30-35 s after the onset of contrast material injection | 1-2.5 | 500 |
Portal venous phase abdomen and pelvis | Acquired 60-65 s after the start of injection | 2.5-5 | 500 |
Delayed phase | Acquired 3-5 min after the start of injection | 5 | 250 |
Table 3 Magnetic resonance imaging protocol
Entry | Feet first | Position | Supine | ||||
Coil type | 8 cardiac or 8 body upper | 8 cardiac or 8 body upper | 8 cardiac or 8 body upper | 8 cardiac or 8 body upper | 8 cardiac or 8 body upper | 8 cardiac or 8 body upper | 8 cardiac or 8 body upper |
Series desc | (1) Axial T2 | (2) ASSET calib | (3) Axial T1 asset | (4) 3D LAVA XV Dyn | (5) Diffusion | (6) 3D 5 min LAVA XV | (7) Fiesta |
Scan plane | Axial | Axial | Axial pre | Axial | Axial | Axial | Coronal |
Image mode | 2D | 2D | 2D in/out phase | 3D | 2D | 3D | 2D |
Pulse seq | FSE-XL | Fast SPGR | Fast SPGR | Fast SPGR | DW EPI | Fast SPGR | Fiesta |
TE1/TE2 (ms) | 85 | FWIP/FWOP | Min Full | Min (~ 50-60) | Min | ||
TR/#R-R (ms) | 4000-6000 | 150-220 | 1200-1800 | ||||
Flip angle | 85 | 15 | NA | 15 | 50-75 | ||
ETL (echo train length) | 16 | ||||||
RCV BW1 (kHz) | 41.67 | 62.50 | 83.33 | (125) | 83.33 | 83-125 | |
FOV (cm) | 34-44 | 48 | 34-44 | 34-42 | 38-44 | 34-44 | 34-44 |
SCAN THK (mm) | 6 | 10 | 5 | 4 | 5 | 4 | 5 |
Spacing/#Loc | 0 | 0 | 0 | -2.0 | 0/36 slices | -2.0 | 0 or -1 |
Freq × phase | 256 × 192 | 256 × 192 | 320 × (160-192) | 100 × 160 | 320 × (160-192) | 192 × 356 | |
NEX | 3-4 | 1 | 1 | 6 | 2 | ||
Phase FOV | 0.75-1.0 | 1.0 | 0.9-1.0 | 0.75-1.0 | 1.0 | 0.70-0.90 | 0.75 –1.0 |
Freq dir | R/L | A/P | R/L | R/L | R/L | R/L | S/I |
Table 4 Extrahepatic bile duct tumors (American Joint Commission on Cancer staging 6th edition)
Tumor | TNM classification |
T1 | Tumor confined to bile duct histologically |
T2 | Tumor beyond the wall of bile duct |
T3 | Tumor invades liver, GB, pancreas, and/or ipsilateral PV (R or L) or hepatic artery (R or L) |
T4 | Tumor invades main portal vein or its branches bilaterally, common hepatic artery, or adjacent structures (colon, stomach, duodenum, abdominal wall) |
Node | |
N0 | No regional lymph node metastasis |
N1 | Regional lymph node metastasis (including hilar, celiac, superior mesenteric, periduodenal and peripancreatic) |
Metastasis | |
M0 | No distant metastasis |
M1 | Distant metastasis |
Tumor stage | AJCC staging 6th edition |
Stage IA | T1, N0, M0 |
Stage IB | T2, N0, M0 |
Stage IIA | T3, N0, M0 |
Stage IIB | T1 or T2 or T3, N1, M0 |
Stage III | T4, any N, M0 |
Stage IV | Any T, any N, M1 |
Table 5 Perihilar bile duct tumors (American Joint Commission on Cancer staging 7th edition)
Tumor | TNM classification |
T1 | Tumor confined to bile duct histologically |
T2a | Tumor beyond the wall of bile duct into adjacent fat |
T2b | Tumor beyond the wall of bile duct into liver parenchyma |
T3 | Tumor invades ipsilateral portal vein (R or L) or hepatic artery (R or L) |
T4 | Tumor invades |
(1) Main portal vein or its branches bilaterally (or) | |
(2) Common hepatic artery (or) | |
(3) The second-order biliary radicals bilaterally | |
(4) Unilateral second-order biliary radicals with contralateral portal vein or hepatic artery involvement | |
Node | |
N0 | No regional lymph node metastasis |
N1 | Regional lymph node metastasis (including nodes along the cystic duct, common bile duct, hepatic artery, and portal vein) |
N2 | Metastasis to periaortic, pericaval, superior mesenteric artery, and/or celiac artery lymph nodes |
Metastasis | |
M0 | No distant metastasis |
M1 | Distant metastasis |
Tumor stage | AJCC staging 6th edition |
Stage I | T1, N0, M0 |
Stage II | T2a-b, N0, M0 |
Stage IIIA | T3, N0, M0 |
Stage IIIB | T1 or T2 or T3, N1, M0 |
Stage IVa | T4, N0 or N1, M0 |
Stage IVb | Any T, N2, M0 or any T, any N, M1 |
Table 6 Distal bile duct tumors (American Joint Commission on Cancer staging 7th edition)
Tumor | TNM classification |
T1 | Tumor confined to bile duct histologically |
T2 | Tumor beyond the wall of bile duct |
T3 | Tumor invades liver, GB, pancreas, but no involvement of celiac axis, or the superior mesenteric artery |
T4 | Tumor involves the celiac axis, or the superior mesenteric artery |
Node | |
N0 | No regional lymph node metastasis |
N1 | Regional lymph node metastasis (including hilar, celiac, superior mesenteric, periduodenal and peripancreatic) |
Metastasis | |
M0 | No distant metastasis |
M1 | Distant metastasis |
Tumor stage | AJCC staging 6th edition |
Stage IA | T1, N0, M0 |
Stage IB | T2, N0, M0 |
Stage IIA | T3, N0, M0 |
Stage IIB | T1 or T2 or T3, N1, M0 |
Stage III | T4, any N, M0 |
Stage IV | Any T, any N, M1 |
- Citation: Ganeshan D, Moron FE, Szklaruk J. Extrahepatic biliary cancer: New staging classification. World J Radiol 2012; 4(8): 345-352
- URL: https://www.wjgnet.com/1949-8470/full/v4/i8/345.htm
- DOI: https://dx.doi.org/10.4329/wjr.v4.i8.345